Abraham Ceesay, Director at Pacira BioSciences, Inc. (PCRX), sold 4,708 shares at $27.19 ($128K) on 2025-09-04, disclosed to the SEC on 2025-09-08.
Scheduled sale ($128k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.19 | 2,354 | $64K | 50.0% |
| 2 | $27.19 | 2,354 | $64K | 50.0% |
| Total | $27.19 avg | 4,708 | $128K | 100% |
| Filing → |
| RAPP | SELL | 2026-08-26 | $938K | — | Filing → |
| RAPP | SELL | 2026-08-12 | $2.4M | — | Filing → |
| RAPP | SELL | 2026-07-29 | $93K | — | Filing → |